title: [Apremilast: Beware of suicidal ideation and behaviour].
authors.affiliation: Département de dermatologie et allergologie, CHRU-hôpital de Brabois, bâtiment des spécialités médicales Philippe Canton, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France. Electronic address: jl.schmutz@chru-nancy.fr.
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D003863:Depression / Q000139:chemically induced* / Q000453:epidemiology; D005602:France / Q000453:epidemiology; D006801:Humans; D015995:Prevalence; D011565:Psoriasis / Q000188:drug therapy; D012307:Risk Factors; D059020:Suicidal Ideation; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013792:Thalidomide; C505730:apremilast